In recent years, the evaluation of the structural properties of food has become of crucial importance in the understanding of food-related disorders. One of the most exciting systems is gliadin, a protein in wheat gluten, that plays a protagonist role in gluten-related disorders with a worldwide prevalence of 5%, including autoimmune celiac disease (CeD) (1%) and non-celiac wheat sensitivity (0.5–13%). It is accepted that gliadin is not fully digested by humans, producing large peptides that reach the gut mucosa. The gliadin peptides cross the lamina propria eliciting different immune responses in susceptible patients. Many clinical and biomedical efforts aim to diagnose and understand gluten-related disorders; meanwhile, the early stages of the inflammatory events remain elusive. Interestingly, although the primary sequence of many gliadin peptides is well known, it was only recently revealed the self-assembly capability of two pathogenic gliadin fragments and their connection to the early stage of diseases. This review is dedicated to the most relevant biophysical characterization of the complex gliadin digest and the two most studied gliadin fragments, the immunodominant 33-mer peptide and the toxic p31-43 in connection with inflammation and innate immune response. Here, we want to emphasize that combining different biophysical methods with cellular and in vivo models is of key importance to get an integrative understanding of a complex biological problem, as discussed here.
By switching the molecular information encoded in the minimalist Ac-Phe-Phe-Cys-NH 2 , it was possible to modulate the organisation of the amyloid fibrils.
The aggregation of proteins into amyloid fibers is linked to more than forty still incurable cellular and neurodegenerative diseases such as Parkinson’s disease (PD), multiple system atrophy, Alzheimer’s disease and type 2 diabetes, among others. The process of amyloid formation is a main feature of cell degeneration and disease pathogenesis. Despite being methodologically challenging, a complete understanding of the molecular mechanism of aggregation, especially in the early stages, is essential to find new biological targets for innovative therapies. Here, we reviewed selected examples on α-syn showing how complementary approaches, which employ different biophysical techniques and models, can better deal with a comprehensive study of amyloid aggregation. In addition to the monomer aggregation and conformational transition hypothesis, we reported new emerging theories regarding the self-aggregation of α-syn, such as the alpha-helix rich tetramer hypothesis, whose destabilization induce monomer aggregation; and the liquid-liquid phase separation hypothesis, which considers a phase separation of α-syn into liquid droplets as a primary event towards the evolution to aggregates. The final aim of this review is to show how multimodal methodologies provide a complete portrait of α-syn oligomerization and can be successfully extended to other protein aggregation diseases.
The self-assembly of endogenous and exogenous peptides into proteolysis-resistant oligomers can trigger toxic cellular events and diseases. In Alzheimer’s disease (AD), the structural polymorphisms of endogenous amyloid-β (Aβ) 1–40 and 1–42 aggregates are essential for their neurotoxic effects. Recent findings on structural differences between brain-derived and in vitro fibrils underscore the need to improve the molecular and supramolecular models of diseases, for example, by stabilizing monomer conformations that lead to disease-relevant structures. In gluten-related disorders (GRDs), particularly celiac disease (CeD), research focuses on exogenous proteolytically resistant gliadin peptides (PRGPs) such as the 33-mer, p31–43, and pepsin-trypsin-derived gliadin peptides. Notably, these PRGPs form nanostructures, which may explain their behavior as nonreplicating pathogens. Thus, understanding their self-assembly has recently gained attention. This review invites both newcomers and experts in the field to tackle the challenges of characterizing peptide self-assembly process as first step to develop successful therapeutic interventions. For AD researchers, it highlights protocols for obtaining monomers and their supramolecular characterization to uncover mechanisms of brain-derived fibril formation, while also showcasing opportunities to explore PRGP nanostructures. For GRD researchers, it offers protocols to obtain PRGP nanostructures and their thorough characterization prior to cellular studies, inspired by approaches in AD research. This review contributes to interdisciplinary efforts toward therapeutic strategies grounded in molecular and supramolecular data by outlining structural insights, characterization protocols, and existing knowledge gaps. Its final aim is to connect established and emerging research domains related to Aβ and gliadin peptides that may have potential applications in peptide self-assembly and the gut-brain axis research, respectively.